These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 10845522

  • 1. Comparative value of 99mTc-sestamibi scintimammography and sonography in the diagnostic workup of breast masses.
    Klaus AJ, Klingensmith WC, Parker SH, Stavros AT, Sutherland JD, Aldrete KD.
    AJR Am J Roentgenol; 2000 Jun; 174(6):1779-83. PubMed ID: 10845522
    [Abstract] [Full Text] [Related]

  • 2. Technetium-99m-sestamibi scintimammography of breast lesions: clinical and pathological follow-up.
    Khalkhali I, Cutrone J, Mena I, Diggles L, Venegas R, Vargas H, Jackson B, Klein S.
    J Nucl Med; 1995 Oct; 36(10):1784-9. PubMed ID: 7562043
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mammography and 99mTc-MIBI scintimammography in suspected breast cancer.
    Prats E, Aisa F, Abós MD, Villavieja L, García-López F, Asenjo MJ, Razola P, Banzo J.
    J Nucl Med; 1999 Feb; 40(2):296-301. PubMed ID: 10025838
    [Abstract] [Full Text] [Related]

  • 5. 99mTc-MIBI and 99mTc-MDP scintimammography for detecting breast carcinoma.
    Chen S, Liu W, Mao Y, Zhu W, Yao Z, Sun X, Xiu Y, Yin Y, Chen J.
    Chin Med J (Engl); 2000 May; 113(5):400-3. PubMed ID: 11776092
    [Abstract] [Full Text] [Related]

  • 6. Positive predictive value of 99mTc sestamibi scintimammography in patients with non-palpable, mammographically detected, suspicious, breast lesions.
    Lumachi F, Zucchetta P, Marzola MC, Ferretti G, Povolato M, Paris MK, Brandes AA, Bui F.
    Nucl Med Commun; 2002 Nov; 23(11):1073-8. PubMed ID: 12411835
    [Abstract] [Full Text] [Related]

  • 7. 99mTc-MIBI prone scintimammography in patients with high and intermediate risk mammography.
    Scopinaro F, Ierardi M, Porfiri LM, Tiberio NS, De Vincentis G, Mezi S, Cannas P, Gigliotti T, Marzetti L.
    Anticancer Res; 1997 Nov; 17(3B):1635-8. PubMed ID: 9179209
    [Abstract] [Full Text] [Related]

  • 8. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions.
    Mekhmandarov S, Sandbank J, Cohen M, Lelcuk S, Lubin E.
    J Nucl Med; 1998 Jan; 39(1):86-91. PubMed ID: 9443742
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evaluation of mammographic breast lesions with Tc-99m sestamibi scintimammography and contrast enhanced MRI.
    Sommer H, Tiling R, Pechmann M, Kindermann G, Kress K, Moser R, Tatsch K, Hahn K, Pfluger T, Assemi C.
    Zentralbl Gynakol; 1997 Jan; 119(1):6-11. PubMed ID: 9050197
    [Abstract] [Full Text] [Related]

  • 11. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement.
    Taillefer R, Robidoux A, Lambert R, Turpin S, Laperrière J.
    J Nucl Med; 1995 Oct; 36(10):1758-65. PubMed ID: 7562039
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of technetium-99m-sestamibi scintimammography with contrast-enhanced MRI for diagnosis of breast lesions.
    Tiling R, Sommer H, Pechmann M, Moser R, Kress K, Pfluger T, Tatsch K, Hahn K.
    J Nucl Med; 1997 Jan; 38(1):58-62. PubMed ID: 8998151
    [Abstract] [Full Text] [Related]

  • 14. Role of technetium tetrofosmin scintimammography in the diagnosis of malignant breast masses and axillary lymph node involvement: a comparative study with mammography and histopathology.
    Ortapamuk H, Ozmen MM, Ibis S, Naldöken S, Aksoy F.
    Eur J Surg; 1999 Dec; 165(12):1147-53. PubMed ID: 10636548
    [Abstract] [Full Text] [Related]

  • 15. The role of Tc-99m methoxyisobutylisonitrile scintimammography as compared to mammography in evaluating palpable breast masses of Taiwanese women.
    Sun SS, Hsieh JF, Tsai SC, Ho YJ, Lee JK, Kao CH.
    Anticancer Res; 2000 Dec; 20(3B):2133-6. PubMed ID: 10928166
    [Abstract] [Full Text] [Related]

  • 16. Scintimammography with Tc-99m sestamibi.
    Khalkhali I, Iraniha S, Cutrone JA, Diggles LE, Klein SR.
    Acta Med Austriaca; 1997 Dec; 24(2):46-9. PubMed ID: 9227786
    [Abstract] [Full Text] [Related]

  • 17. Technetium-99m sestamibi scintimammography: the influence of histopathological characteristics, lesion size and the presence of carcinoma in situ in the detection of breast carcinoma.
    Howarth D, Sillar R, Clark D, Lan L.
    Eur J Nucl Med; 1999 Nov; 26(11):1475-81. PubMed ID: 10552090
    [Abstract] [Full Text] [Related]

  • 18. Tc-99m-tetrofosmin scintimammography: a prospective study in primary breast lesions.
    Lind P, Gallowitsch HJ, Kogler D, Kresnik E, Mikosch P, Gomez I.
    Nuklearmedizin; 1996 Dec; 35(6):225-9. PubMed ID: 8976502
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.